IMPLICATOR
Operand, a New York startup that provides an AI due diligence platform for private equity, raised $31 million across seed and Series A funding at a $220 million valuation. Khosla Ventures led the round. Operand's AI agent platform is designed to uncover customer behavior, pricing discrepancies and operational metrics without relying on seller cooperation.
What Changed
- Operand raised $31 million across seed and Series A funding at a $220 million valuation, in a round led by Khosla Ventures.
- Its AI agent platform is designed to uncover customer behavior, pricing discrepancies and operational metrics without relying on seller cooperation.
- On Nov. 10, Charta Health announced a $55 million Series B led by Insight Partners for AI medical chart review, bringing its total funding to $85 million.
- Charta's tenfold revenue growth over the last 12 months comes from the company's own press release.
AI-generated summary, reviewed by an editor. More on our AI guidelines.
What Operand sells
Ram Gorthi, Akhil Iyengar and Arjun Sahney founded the company. Its platform helps buyout firms rebuild businesses from public records and internet traces to conduct autonomous due diligence. The agents analyze public traces, customer overlap and market positioning.
The funding write-up names Clearlake Capital as one private equity firm the technology enables to perform due diligence and turnarounds.
Felicis, SV Angel, Soma Capital and Y Combinator joined the round. Keith Rabois joined the company's board of directors. Operand plans to use the money to expand its operations and scale its AI agent platform.
A second bet on reading documents
On Nov. 10, Charta Health, a San Francisco company whose AI medical chart review platform is built for billing accuracy, announced a $55 million Series B led by Insight Partners. Existing investors Madrona, Bain Capital Ventures and South Park Commons participated, alongside QuantumLight. The round brings Charta's total funding to $85 million and is its third in less than two years.
FREE · ABOUT FIVE MINUTES
Follow the money behind AI that reads the paperwork.
Implicator cuts the flood to the developments worth your attention, with concise reporting on what changed and why it matters. Delivered every weekday at 4:45 a.m. Pacific, 7:45 a.m. Eastern.
From San Francisco. No spam. Unsubscribe anytime.
"We came to healthcare as engineers and saw a system where the most important data was locked in documents no one had time to read," said Justin Liu, Charta's chief executive and co-founder.
Charta's AI reads clinical documentation the way an expert coder and auditor would. It flags missing codes the chart supports and removes those the documentation doesn't adequately support. Liu and Scott Morris, the chief technology officer, came from Rockset, the real-time AI data company that became OpenAI's first product acquisition. Before building Charta, the two spent a year earning Certified Professional Coder credentials and interviewed more than 100 healthcare leaders. Charta now requires its engineering and growth teams to get certified in medical coding as well.
Alongside the round, Charta launched Charta for Payers, a suite of six AI-powered products for health plans. The company designed the suite in partnership with one of the nation's largest health insurers.
The money in the claims fight
Charta's release cites a 2025 study that estimated claims adjudication cost hospitals and health systems more than $25 billion in 2023. Nearly $18 billion of that total was potentially wasted on a cycle of denials and appeals.
The same release adds that the cycle has worsened as insurers and healthcare providers each adopt AI tools that generate more denials and appeals. Charta's response is to bring the same AI to both sides, so health plans and providers work from shared standards of accuracy before a claim is submitted.
Know someone who'd find this useful? ✉️ Email it to a friend in one click, or they can subscribe free here.
Other companies work the same space. Arintra, a San Francisco company focused on healthcare revenue assurance, raised $25 million in Series B funding earlier this year, bringing its total raise to $51 million. Candid Health secured $120 million in Series D funding this year and said the round tripled its valuation from its February 2025 Series C. CodaMetrix, an AI medical coding company, picked up $40 million in funding in 2024.
What the numbers cover
Charta says it grew revenue 10x in the last 12 months. That figure comes from the company's own press release. The funding write-ups for both companies describe what the platforms are designed to do.
Charta lists American Family Care, Grow Therapy and Pediatric Associates Family of Companies among its customers.
"Charta helps us review charts at a scale that wouldn't be possible manually, so our clinicians can stay focused on care," said Brynna Pietz, vice president of clinical and insurance operations at Grow Therapy.
Frequently Asked Questions
What does Operand do?
Operand provides an AI due diligence platform for private equity. It helps buyout firms rebuild businesses from public records and internet traces to conduct autonomous due diligence, analyzing public traces, customer overlap and market positioning.
Who invested in Operand?
Khosla Ventures led the $31 million round, with participation from Felicis, SV Angel, Soma Capital and Y Combinator. Keith Rabois joined the company's board of directors.
Who founded Operand?
Ram Gorthi, Akhil Iyengar and Arjun Sahney founded the New York company.
What did Charta Health raise?
Charta Health announced a $55 million Series B led by Insight Partners on Nov. 10. The round brings its total funding to $85 million and is its third in less than two years.
How does Charta's AI work?
Charta's AI reads clinical documentation the way an expert coder and auditor would, flagging missing codes the chart supports and removing those the documentation doesn't adequately support.
AI-generated summary, reviewed by an editor. More on our AI guidelines.
Free AI briefing · Weekdays
The AI stories that matter, sourced and explained.
Join the Morning Briefing. It goes out every weekday at 4:45 a.m. Pacific, with later sends for the East Coast, Berlin and Tokyo.
Free when you sign up: The Paperclip Compendium, our tested guide to running AI agents.
Free. Unsubscribe in one click.
Marcus Schuler
Editor-in-Chief and founder of Implicator.ai. Former ARD correspondent and senior broadcast journalist with 10+ years covering tech. Writes daily briefings on policy and market developments. Based in San Francisco. E-mail: editor@implicator.ai
